Cwm, LLC Blueprint Medicines Corp Transaction History

Cwm, LLC

$23.3 Billion
Q3 2024

A detailed history of Cwm, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Cwm, LLC holds 1,870 shares of BPMC stock, worth $176,902. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,870

Previous 1,105 69.23%

Holding current value

$176,902

Previous $119,000 45.38%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$84.1 - $120.5 $64,336 - $92,182	765 Added 69.23%	1,870 $173,000
Q2 2024 Jul 09, 2024	BUY	$85.18 - $108.78 $50,256 - $64,180	590 Added 114.56%	1,105 $119,000
Q1 2024 Apr 05, 2024	BUY	$73.17 - $99.79 $4,682 - $6,386	64 Added 14.19%	515 $49,000
Q4 2023 Feb 01, 2024	SELL	$43.96 - $92.84 $3,516 - $7,427	-80 Reduced 15.07%	451 $42,000
Q3 2023 Oct 11, 2023	BUY	$46.9 - $66.0 $5,393 - $7,590	115 Added 27.64%	531 $27,000
Q2 2023 Aug 03, 2023	SELL	$42.2 - $66.37 $422 - $663	-10 Reduced 2.35%	416 $26,000
Q1 2023 Apr 28, 2023	SELL	$37.97 - $50.0 $5,809 - $7,650	-153 Reduced 26.42%	426 $19,000
Q4 2022 Feb 01, 2023	BUY	$41.06 - $66.48 $8,786 - $14,226	214 Added 58.63%	579 $25,000
Q3 2022 Oct 27, 2022	BUY	$49.93 - $77.7 $2,097 - $3,263	42 Added 13.0%	365 $24,000
Q2 2022 Jul 28, 2022	SELL	$45.23 - $70.15 $497 - $771	-11 Reduced 3.29%	323 $16,000
Q1 2022 Apr 21, 2022	BUY	$54.1 - $110.08 $757 - $1,541	14 Added 4.38%	334 $21,000
Q4 2021 Jan 31, 2022	BUY	$94.25 - $115.99 $377 - $463	4 Added 1.27%	320 $34,000
Q1 2021 Sep 15, 2021	BUY	$90.71 - $108.28 $26,578 - $31,726	293 Added 1273.91%	316 $28,000
Q1 2021 Apr 27, 2021	SELL	$90.71 - $108.28 $26,578 - $31,726	-293 Reduced 92.72%	23 $2,000
Q4 2020 Sep 15, 2021	BUY	$92.08 - $124.48 $26,979 - $36,472	293 Added 1273.91%	316 $28,000
Q4 2020 Jan 27, 2021	SELL	$92.08 - $124.48 $26,979 - $36,472	-293 Reduced 92.72%	23 $3,000
Q3 2020 Sep 15, 2021	BUY	$66.45 - $92.7 $19,469 - $27,161	293 Added 1273.91%	316 $28,000
Q3 2020 Oct 19, 2020	SELL	$66.45 - $92.7 $19,469 - $27,161	-293 Reduced 92.72%	23 $2,000
Q2 2020 Sep 15, 2021	BUY	$57.09 - $79.27 $18,040 - $25,049	316 New	316 $28,000
Q2 2020 Jul 22, 2020	SELL	$57.09 - $79.27 $18,040 - $25,049	-316 Closed	0 $0
Q1 2020 Sep 15, 2021	BUY	$48.11 - $82.22 $15,202 - $25,981	316 New	316 $28,000
Q1 2020 Apr 28, 2020	SELL	$48.11 - $82.22 $15,202 - $25,981	-316 Closed	0 $0
Q4 2019 Sep 14, 2021	BUY	$66.73 - $82.59 $21,086 - $26,098	316 New	316 $28,000
Q4 2019 Jan 27, 2020	SELL	$66.73 - $82.59 $21,086 - $26,098	-316 Closed	0 $0
Q3 2019 Sep 14, 2021	BUY	$72.9 - $101.41 $23,036 - $32,045	316 New	316 $28,000
Q3 2019 Oct 22, 2019	SELL	$72.9 - $101.41 $23,036 - $32,045	-316 Closed	0 $0
Q2 2019 Sep 14, 2021	BUY	$73.54 - $97.8 $23,238 - $30,904	316 New	316 $28,000
Q2 2019 Jul 31, 2019	SELL	$73.54 - $97.8 $23,238 - $30,904	-316 Closed	0 $0
Q1 2019 Sep 02, 2021	BUY	$48.7 - $86.6 $15,389 - $27,365	316 New	316 $0

Others Institutions Holding BPMC

# of Institutions

350

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.65B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account